Clinical Trial Update: Effect of Lifitegrast 5% on Tear Film Markers [Phase 4]

View source ↗

Summary

Phase 4 trial investigating Lifitegrast 5% effects on tear film markers has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye
• Dry Eye Syndromes
• Dry Eyes Chronic

Drugs mentioned

• Lifitegrast 5% (lifitegrast)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Dry Eye, Dry Eye Syndromes | Phase 4 | Status: WITHDRAWN